Cellecta Receive Grant to Develop CRISPR Technology Monday, July 20, 2015 The company has announced the receipt of Phase I SBIR grant funds from the National Institute of Health (NIH) to further its CRISPR-mediated genome-editing program.Can Cell Cycle Protein Prevent or Kill Breast Cancer Tumors? Monday, July 20, 2015 An MD Anderson study has shown the potential of a simple molecule involved in cancer metabolism as a powerful therapeutic. RNAi Screening Trends Friday, July 17, 2015 Understand current trends and learn which application areas are expected to gain in popularity over the next few years.A Novel Drug to FIght Malaria Friday, July 17, 2015 An international team of scientists has announced that a new compound to fight malaria is ready for human trials.NCI Announces Funding Opportunity for Biospecimen Core Thursday, July 16, 2015 The National Cancer Institute's Office of Cancer Clinical Proteomics Research has announced a funding opportunity for establishing a Biospecimen Core Resource.Eco-Friendly Nanobullet to Battle Bacteria Thursday, July 16, 2015 Researchers have developed a method to combat bacteria by engineering nanoscale particles that add the antimicrobial potency of silver to a core of lignin, a ubiquitous substance found in all plant cells. Rubicon Genomics Raises $2M Thursday, July 16, 2015 Rubicon Genomics today announced it has secured $2 million in growth capital financing.BMS Partners with Medical University Thursday, July 16, 2015 The Medical University of South Carolina and Bristol-Myers Squibb Company have announced that they have entered into a collaboration focused on fibrotic diseases, including scleroderma, renal fibrosis and idiopathic pulmonary fibrosis. InSphero AG Secures CHF 20 Million Series C Financing Wednesday, July 15, 2015 3D cell culture company gains new long-term investor to fuel expansion of global operations and product portfolio.